20-F: Raytech Holding Reports Strong Revenue Growth

Sentiment:

Annual Report


Raytech Holding Limited announced a significant increase in revenue for the fiscal year ended March 31, 2026, driven by the expansion of its service businesses and continued growth in its core product segment.

Capital raiseThe company completed a follow-on public offering in July 2025, raising net proceeds of approximately US$4.68 million.In June 2026, the company closed a registered direct offering, raising approximately US$6.2 million.

Summary

  • Raytech Holding Limited reported a substantial revenue increase of 81.1% to HKD142,629,085 (US$18,192,485) for the fiscal year ended March 31, 2026.
  • This growth was primarily fueled by new service income from Raytech Innovation and Worry free, contributing HKD44,194,236 (31.0%) to total revenue.
  • The company's core business, sourcing and wholesaling of personal care electrical appliances, also saw a 26.2% increase in sales.
  • Net income rose by 101.9% to HKD16,690,575 (US$2,128,900) for the same period.
  • The company is strategically expanding into personal health care electronics and marketing solutions.
  • Raytech Holding completed a registered direct offering in June 2026, raising approximately US$6.2 million.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively due to significant revenue and net income growth, driven by successful business diversification. However, risks related to customer concentration, reliance on a single manufacturer, and internal control weaknesses temper the overall sentiment.

Positives

  • Revenue increased by 81.1% to HKD142,629,085 (US$18,192,485) for the fiscal year ended March 31, 2026.
  • Net income increased by 101.9% to HKD16,690,575 (US$2,128,900).
  • Service businesses (product design, development, advisory, and marketing solutions) contributed 31.0% of total revenue.
  • Sales of personal care electrical appliances increased by 26.2%.
  • The company successfully regained compliance with Nasdaq's minimum bid price requirement through a share consolidation.
  • Completed a registered direct offering in June 2026, raising approximately US$6.2 million to bolster liquidity and fund expansion.

Negatives

  • Operating activities used net cash of HKD14,511,287 (US$1,850,928) for the year ended March 31, 2026, primarily due to the build-up of accounts receivable from new service businesses.
  • Significant customer concentration, with one customer accounting for 62.5% of total revenues for the year ended March 31, 2026.
  • Heavy reliance on a single manufacturer, Zhongshan Raytech, which accounted for 62.1% of total purchases for the year ended March 31, 2026.
  • Identified material weaknesses in internal control over financial reporting related to inadequate segregation of duties and insufficient financial reporting personnel.
  • The company does not intend to pay dividends for the foreseeable future.

Risks

  • The company faces substantial customer concentration risk, with one customer accounting for 62.5% of its revenue in fiscal year 2026.
  • There is a significant reliance on Zhongshan Raytech, a related party manufacturer, for production, posing a risk if this relationship is disrupted.
  • The company's expansion into personal health care electronics is relatively new and may not be successfully commercialized.
  • Potential for inadequate or inaccurate internal and external information leading to flawed financial forecasts and decisions.
  • The company is subject to risks associated with doing business in Hong Kong, including potential government oversight and changes in regulations.
  • The company received a deficiency notice from Nasdaq regarding the minimum bid price requirement and may face future delisting if compliance is not maintained.
  • Future sales of ordinary shares could cause substantial dilution and adversely affect the market price.
  • The company has identified material weaknesses in internal controls over financial reporting.

Future Outlook

The company plans to continue expanding its service businesses (product design, development, advisory, and marketing solutions) and its core sourcing and wholesaling of personal care electrical appliances. It aims to explore new product lines, broaden sales through technical expertise, and approach customers in Europe, the US, and other Asian markets.

Management Comments

  • The company believes its strong reputation, R&D expertise, and close customer relationships position it well for future growth.
  • Management aims to become a leading product design and development office in the personal care and lifestyle electrical appliances industry in Asia.
  • The company is committed to recruiting, retaining, and developing qualified personnel to support its growth.

Industry Context

StockSavvy.ai notes that Raytech Holding's strategic shift towards service-based revenue streams in personal health care electronics aligns with broader industry trends favoring specialized design and development services. The company's continued reliance on manufacturing in China, however, exposes it to geopolitical and trade policy risks.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorMr. Ling Chun Yin2026-01-02Resignation
Independent DirectorMs. Li Wan Venus2026-01-02Resignation
DirectorMr. Yuan Tianfu2026-01-02Appointment to fill vacancy
Independent DirectorDr. Wang Shibin2026-01-02Appointment to fill vacancy
Chairman of the BoardMr. Ching Tim HoiMr. Liu Haoyuan2026-04-15Appointment
Executive DirectorMr. Ching Tim HoiMr. Ching Tim Hoi2026-04-15Continues to serve as CEO and Executive Director

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Audit CommitteeMembers are Dr. Wang Shibin, Mr. Fok Pak Kin Charles, and Mr. Li Shihua. Mr. Li Shihua is the chairman.Oversees accounting and financial reporting, appoints auditors, reviews internal controls.
Compensation CommitteeMembers are Dr. Wang Shibin, Mr. Fok Pak Kin Charles, and Mr. Li Shihua. Mr. Fok Pak Kin Charles is the chairman.Reviews and approves compensation for directors and executive officers.
Nominating and Corporate Governance CommitteeMembers are Dr. Wang Shibin, Mr. Fok Pak Kin Charles, and Mr. Li Shihua. Dr. Wang Shibin is the chairperson.Identifies and recommends director nominees, advises on corporate governance.
Reliance on Home Country PracticeRelied on home country practice exemption for shareholder approval requirements in the June 2026 registered direct offering.2026-06-29May afford less protection to shareholders compared to full Nasdaq governance standards.

Legal Proceedings

  • The company and its subsidiaries are not currently party to any material legal or administrative proceedings.

Related Party Transactions

  • Purchases of products from Zhongshan Raytech, an entity controlled by CEO Mr. Ching Tim Hoi, amounted to HKD65,276,881 (US$8,326,133) for the year ended March 31, 2026.
  • Accounts payable to Zhongshan Raytech were HKD19,972,442 (US$2,547,505) as of March 31, 2026.
  • Lease of principal executive office from Raytech Holdings Company Limited, an entity controlled by Mr. Ching, for HKD300,000 (US$38,265) for the year ended March 31, 2026.
  • Affiliate investors Fortune Genesis Holdings Limited and WK Frater Holdings Limited participated in the June 2026 registered direct offering.
  • A promissory note of US$2,000,000 was issued to Ms. Wang Yafeng, the vendor of Worry free, as part of the acquisition consideration.

Stakeholder Impact

  • Shareholders may experience dilution from future equity issuances and potential adverse effects on share price due to volatility and market perception.
  • The company's reliance on a few major customers could impact revenue stability for suppliers.
  • Employees are subject to the company's insider trading policy and potential disciplinary actions for violations.

Next Steps

  • Continue to expand service businesses (product design, development, advisory, and marketing solutions).
  • Grow sourcing and wholesaling of personal care electrical appliances.
  • Explore new product lines and expand into European, US, and other Asian markets.
  • Recruit and retain qualified personnel.
  • Address material weaknesses in internal control over financial reporting.

Key Dates

DateDescription
2023-05-10Amended and restated memorandum and articles of association filed.
2024-05-13Registration statement on Form F-1 declared effective by SEC.
2024-05-15Ordinary Shares commenced trading on The Nasdaq Capital Market under the symbol RAY.
2025-07-01Closed a follow-on public offering of ordinary shares.
2025-10-14Received notice from Nasdaq regarding minimum bid price deficiency.
2025-11-071-for-16 share consolidation became effective.
2025-12-29Acquisition of Worry free Group (Hong Kong) Limited completed.
2026-06-29Closed a registered direct offering.

Recommendation

hold

The company shows strong growth and has successfully diversified its revenue streams. However, significant risks remain, including customer concentration, reliance on a related-party manufacturer, and identified material weaknesses in internal controls. While the expansion into services is positive, these risks warrant a cautious 'hold' rating until these issues are adequately addressed and mitigated.

Keywords

Raytech Holding, Form 20-F, Annual Report, Personal Care Appliances, Product Design, Marketing Solutions, Hong Kong, Nasdaq

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.